BBOT
Price
$12.00
Change
+$1.35 (+12.68%)
Updated
Aug 18, 04:59 PM (EDT)
Capitalization
843.44M
16 days until earnings call
CORT
Price
$71.70
Change
-$0.05 (-0.07%)
Updated
Aug 18, 04:59 PM (EDT)
Capitalization
7.56B
72 days until earnings call
Interact to see
Advertisement

BBOT vs CORT

Header iconBBOT vs CORT Comparison
Open Charts BBOT vs CORTBanner chart's image
BridgeBio Oncology Therapeutics
Price$12.00
Change+$1.35 (+12.68%)
Volume$700
Capitalization843.44M
Corcept Therapeutics
Price$71.70
Change-$0.05 (-0.07%)
Volume$17.48K
Capitalization7.56B
BBOT vs CORT Comparison Chart in %
Loading...
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBOT vs. CORT commentary
Aug 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBOT is a Hold and CORT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 19, 2025
Stock price -- (BBOT: $10.65 vs. CORT: $71.75)
Brand notoriety: BBOT and CORT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBOT: 85% vs. CORT: 59%
Market capitalization -- BBOT: $843.44M vs. CORT: $7.56B
BBOT [@Biotechnology] is valued at $843.44M. CORT’s [@Biotechnology] market capitalization is $7.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBOT’s FA Score shows that 1 FA rating(s) are green whileCORT’s FA Score has 1 green FA rating(s).

  • BBOT’s FA Score: 1 green, 4 red.
  • CORT’s FA Score: 1 green, 4 red.
According to our system of comparison, CORT is a better buy in the long-term than BBOT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBOT’s TA Score shows that 5 TA indicator(s) are bullish while CORT’s TA Score has 5 bullish TA indicator(s).

  • BBOT’s TA Score: 5 bullish, 1 bearish.
  • CORT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CORT is a better buy in the short-term than BBOT.

Price Growth

BBOT (@Biotechnology) experienced а +5.86% price change this week, while CORT (@Biotechnology) price change was -0.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.86%. For the same industry, the average monthly price growth was +22.78%, and the average quarterly price growth was +23.29%.

Reported Earning Dates

BBOT is expected to report earnings on Sep 03, 2025.

CORT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+8.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORT($7.56B) has a higher market cap than BBOT($843M). CORT YTD gains are higher at: 42.379 vs. BBOT (1.429).
BBOTCORTBBOT / CORT
Capitalization843M7.56B11%
EBITDAN/A104M-
Gain YTD1.42942.3793%
P/E RatioN/A64.06-
RevenueN/A716M-
Total CashN/A342M-
Total DebtN/A6.61M-
FUNDAMENTALS RATINGS
CORT: Fundamental Ratings
CORT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
42
SMR RATING
1..100
43
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBOTCORT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
47%
Bearish Trend 4 days ago
69%
Momentum
ODDS (%)
Bullish Trend 4 days ago
14%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bullish Trend 4 days ago
8%
Bullish Trend 4 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
24%
Bearish Trend 4 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
7%
Bearish Trend 4 days ago
63%
Advances
ODDS (%)
Bullish Trend 4 days ago
16%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
65%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
27%
Bearish Trend 4 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSJAX66.650.34
+0.51%
Cohen & Steers Realty Shares A
RFISX17.39-0.06
-0.34%
Ranger Small Cap Institutional
QMORX24.03-0.10
-0.41%
AQR Large Cap Momentum Style R6
CEIIX13.99-0.06
-0.43%
Manning & Napier Callodine Equity Inc I
RLITX16.27-0.20
-1.21%
Lazard International Strategic Eq R6

BBOT and

Correlation & Price change

A.I.dvisor tells us that BBOT and COCP have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BBOT and COCP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBOT
1D Price
Change %
BBOT100%
+6.61%
COCP - BBOT
25%
Poorly correlated
+0.89%
CORT - BBOT
21%
Poorly correlated
-0.35%
AIM - BBOT
3%
Poorly correlated
+3.11%
IMA - BBOT
1%
Poorly correlated
-3.99%
LIMN - BBOT
0%
Poorly correlated
-2.91%
More

CORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORT has been loosely correlated with DNLI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORT
1D Price
Change %
CORT100%
-0.35%
DNLI - CORT
40%
Loosely correlated
+1.66%
TENX - CORT
38%
Loosely correlated
+0.34%
ARCT - CORT
38%
Loosely correlated
+1.30%
HNSBF - CORT
38%
Loosely correlated
N/A
INSM - CORT
34%
Loosely correlated
+0.04%
More